Wellcome cites higher sales to fend off Glaxo

The £9bn bid from Glaxo for Wellcome stepped up a gear yesterday as Wellcome published higher-than-expected sales forecasts for four of its biggest drugs and the Wellcome Trust, its biggest shareholder, sought court consent to sell to Glaxo.

Wellcome predicted a 36 per cent increase in combined sales over the next four years for Zovirax and Valtrex, its herpes and shingles treatments, and anti-epileptic Lamictal and Aids drug Retrovir.

Wellcome said the expected growth rates for Lamictal and Valtrex, the sales of which are currently negligible, were better than the City was expecting and would more than make up for declining sales of Zovirax after its patent expires in 1997.

John Robb, chief executive, said the forecasts underlined the extent to which Glaxo's offer undervalued Wellcome. He also criticised the bid for being 30 per cent dependent on Glaxo shares which, he said, had "uncertain value" following last year's decline in earnings per share and falling sales of Zantac, Glaxo's biggest-selling drug.

Sir Richard Sykes, chief executive of Glaxo, poured cold water on the defence: "Wellcome does not dispute the commercial logic of our bid, nor the changes now taking place in the pharmaceutical industry which are driving its consolidation. Our offer is generous. It is the only offer and Wellcome shareholders should accept it now."

Mr Robb refused to be drawn on the state of negotiations with third-party potential bidders. He said it would be surprising if a buyer showed its hand much before the 28 February deadline set by the Wellcome Trust, after which it would irrevocably commit to accepting Glaxo's offer.

The trust was in the High Court yesterday for a hearing, adjourned until today, to determine whether it can reduce its holding below 25 per cent, the limit set by the court last time it sold a tranche of shares in a public offering in 1992.

Robin Gilbert, an analyst at Panmure Gordon, said the forecasts, which envisaged sales of the four drugs rising from £1.13bn last year to £1.54bn in 1998, were reasonable and in line with his own expectations.

Sales of Zovirax, which accounts for about 40 per cent of Wellcome's sales, are forecast by the company to peak this year at £942m before declining to £598m over the following three years.

Valtrex, its successor, however, is expected to increase its sales from just £18m this year to almost £300m by 1988.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
News
ebooksNow available in paperback
News
The 67P/CG comet as seen from the Philae lander
scienceThe most important scientific breakthroughs of 2014
Arts and Entertainment
Ian McKellen as Gandalf in The Hobbit: The Battle Of The Five Armies
film
Sport
football
Arts and Entertainment
Sarah Koenig, creator of popular podcast Serial, which is to be broadcast by the BBC
tvReview: The secret to the programme's success is that it allows its audience to play detective
News
Ruby Wax has previously written about her mental health problems in her book Sane New World
people
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Marketing Services Manager - (communications, testing, DM)

£32000 - £35000 per annum + benefits: Ashdown Group: Marketing Services Manage...

Guru Careers: Finance Account Manager

£Neg. (DOE) + Excellent Benefits: Guru Careers: A Finance Account Manager with...

Ashdown Group: Java Developer - Hertfordshire - £47,000 + bonus + benefits

£40000 - £470000 per annum + bonus: Ashdown Group: Java Developer / J2EE Devel...

Ashdown Group: Direct Marketing Manager - B2C, Financial Services - Slough

£45000 - £55000 per annum + Benefits: Ashdown Group: An exciting opportunity h...

Day In a Page

Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas